HR 1064 Re-checks Congress.gov for new actions and updates the bill's status, and fills in any sponsors, committees, or related bills that are missing. It does not re-pull sponsors/cosponsors/committees/related — those rarely change — and it skips all work if nothing has changed upstream, so it's cheap to click.
Stopping Overdoses of Fentanyl Analogues Act
To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.
Summary
This bill amends the Controlled Substances Act to classify fentanyl-related substances as Schedule I controlled substances. Fentanyl-related substances are defined as materials containing substances structurally similar to fentanyl, including those with specific chemical modifications and their salts and isomers. The bill treats these substances as fentanyl analogues for criminal penalty purposes and takes effect one day after enactment.
AI-generated plain-language summary of the bill text — neutral, and may be imperfect. See the full text below for the exact wording.
Sponsor (1)
Actions (2)
- Feb 6, 2025 Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. · house
- Feb 6, 2025 Introduced in House
More bills on these subjects (8)
Other bills that carry the most legislative subjects in common with this one (topical discovery — distinct from the procedural related bills above).
Similar bills (6)
Bills with similar text or summary — includes reintroductions across Congresses. Ranked by semantic similarity of the bill text (computed locally); a neutral discovery aid, not a claim the bills are duplicates.
Text versions (1)
Bills are re-published as they move (Introduced → Reported → Engrossed → Enrolled …). Each stage below is a separate text; pick two to see what changed. Data from Congress.gov.
Full text
IN THE HOUSE OF REPRESENTATIVES
February 6, 2025
Mr. Fitzgerald introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned
A BILL
To amend the Controlled Substances Act to list fentanyl-related substances as schedule I controlled substances.
Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled,
SECTION 1. SHORT TITLE.
This Act may be cited as the “Stopping Overdoses of Fentanyl Analogues Act”.
SEC. 2. ARCHIE BADURA MEMORIAL FENTANYL RELATED SUBSTANCE SCHEDULING.
Section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended by adding at the end of schedule I the following:
“(e)(1) Unless specifically exempted or unless listed in another schedule, any material, compound, mixture, or preparation which contains any quantity of fentanyl-related substances, or which contains their salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible within the specific chemical designation.
“(2) In paragraph (1), the term ‘fentanyl-related substances’ includes any substance that is structurally related to fentanyl by one or more of the following modifications:
“(A) By replacement of the phenyl portion of the phenethyl group by any monocycle, whether or not further substituted in or on the monocycle.
“(B) By substitution in or on the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halo, haloalkyl, amino or nitro groups.
“(C) By substitution in or on the piperidine ring with alkyl, alkenyl, alkoxy, ester, ether, hydroxy, halo, haloalkyl, amino or nitro groups.
“(D) By replacement of the aniline ring with any aromatic monocycle whether or not further substituted in or on the aromatic monocycle.
“(E) By replacement of the N-propionyl group by another acyl group.”.
SEC. 3. PENALTIES.
A fentanyl-related substance shall be treated as an analogue of N- phenyl-N-[1-(2-phenylethyl)-4-piperidinyl] propanamide under section 401(b)(1) of the Controlled Substances Act (21 U.S.C. 841(b)(1)) and section 1010(b) of the Controlled Substances Import and Export Act (21 U.S.C. 960(b)) without requiring proof that a fentanyl-related substance meets the definition of a controlled substance analogue under section 102 of the Controlled Substances Act (21 U.S.C. 802).
SEC. 4. EFFECTIVE DATE.
This Act shall take effect one day after the date of enactment of this Act. <all>
Comments